Sucralfate Tablet
Product Images NDC 70518-3987

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 70518-3987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Sucralfate is a medication available in tablet form. This specific package contains 30 tablets. It is a prescription medication, meaning it can only be obtained with a doctor's authorization. The package includes an NDC number and the expiration date is not provided. The medication is manufactured by Greenstone LLC in Peapack, NJ. It is important to keep this medication out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Sucralfate Tablets Contain Sucralfate And Sucralfate Is An α-d-glucopyranoside, β-d-fructofuranosyl-, Octakis-(hydrogen Sulfate), Aluminum Complex. (Sucralfate 01)

Sucralfate Tablets Contain Sucralfate And Sucralfate Is An α-d-glucopyranoside, β-d-fructofuranosyl-, Octakis-(hydrogen Sulfate), Aluminum Complex. (Sucralfate 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.